Lipid management: tools for getting to the goal.

Area of Science:

• Cardiology
• Pharmacology
• Public Health

Background:

• Elevated low-density lipoprotein cholesterol (LDL-C) is a primary target for hypercholesterolemia treatment in the U.S.
• An optimal LDL-C level is defined as < 100 mg/dL.
• Lifestyle modification is the initial step in managing elevated LDL-C.

Purpose of the Study:

• To outline the current treatment strategies for hypercholesterolemia in the United States.
• To detail the role of lifestyle modifications and pharmacotherapy in achieving lipid management goals.

Main Methods:

• Review of current guidelines and therapeutic options for hypercholesterolemia.
• Discussion of first-line and alternative lipid-lowering drug therapies.
• Exploration of combination therapy approaches for LDL-C and triglyceride management.

Main Results:

• Lifestyle modifications include dietary changes, increased physical activity, and weight management.
• Statins are the preferred first-line pharmacotherapy for most patients.
• Alternative agents (bile acid resins, niacin) and combination therapies are effective for specific patient populations or goals.

Conclusions:

• Achieving target LDL-C levels is crucial for managing hypercholesterolemia.
• Pharmacotherapy, particularly statins, is often necessary for patients who do not meet goals with lifestyle changes alone.
• Comprehensive lipid management involves reaching specific cholesterol targets and addressing other cardiovascular disease risk factors.